Title: 
Official Title: To amend the Internal Revenue Code of 1986 to deny the deduction for
            advertising and promotional expenses for certain drugs.
Number of Sections: 3
Source: versions - Introduced in Senate
Media Type: text/xml

================================================================================

Section 1:
1.
            Short title
 This Act may be cited as the No Handouts for Drug Advertisements Act.

Section 2:
2.
            Disallowance of deduction for advertising and promotional expenses for certain
                drugs
            
                (a)
                In general
 Part IX of subchapter B of chapter 1 of subtitle A of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:
                
                    
                        280I.
                        Disallowance of deduction for direct-to-consumer advertising of
                            certain drugs
                        
                            (a)
                            In general
 No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of covered drugs for any taxable year.
                        
                        
                            (b)
                            Direct-to-Consumer advertising
 For purposes of this section—  (1) In general The term direct-to-consumer advertising means any dissemination, by or on behalf of a covered entity, of an advertisement which—
                                
                                    (A)
 is in regard to a covered drug, and   (B) primarily targeted to the general public, including through—
                                    
                                        (i)
 broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and
                                    
                                    
                                        (ii)
 dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications).
                                    
                                
                            
                            
                                (2)
                                Exception
 Such term shall not include an advertisement made through publication in journals and other periodicals.
                            
                            
                                (3)
                                Other terms
 For purposes of this subsection—
                                
                                    (A)
                                    Covered entity
 The term covered entity means—  (i) a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or
                                    
                                    
                                        (ii)
 a person that owns an outsourcing facility (as such term is defined in section 503B(d)(4) of such Act), either directly or indirectly through a subsidiary.
                                    
                                
                                
                                    (B)
                                    Covered drug
 The term covered drug means—  (i) a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or
                                    
                                    
                                        (ii)
 a drug compounded in accordance with section 503A or 503B of such Act.
                                    
                                
                            
                        
                    
                    .
                
            
            
                (b)
                Conforming amendment
 The table of sections for such part IX of the Internal Revenue Code of 1986 is amended by adding after the item relating to section 280H the following new item:
                
                    
                        Sec.
                            280I. Disallowance of deduction for direct-to-consumer advertising of
                            certain drugs.
                    
                    .
                
            
            
                (c)
                Effective date
 The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.

Section 3:
280I.
                        Disallowance of deduction for direct-to-consumer advertising of
                            certain drugs
                        
                            (a)
                            In general
 No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of covered drugs for any taxable year.
                        
                        
                            (b)
                            Direct-to-Consumer advertising
 For purposes of this section—  (1) In general The term direct-to-consumer advertising means any dissemination, by or on behalf of a covered entity, of an advertisement which—
                                
                                    (A)
 is in regard to a covered drug, and   (B) primarily targeted to the general public, including through—
                                    
                                        (i)
 broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and
                                    
                                    
                                        (ii)
 dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications).
                                    
                                
                            
                            
                                (2)
                                Exception
 Such term shall not include an advertisement made through publication in journals and other periodicals.
                            
                            
                                (3)
                                Other terms
 For purposes of this subsection—
                                
                                    (A)
                                    Covered entity
 The term covered entity means—  (i) a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or
                                    
                                    
                                        (ii)
 a person that owns an outsourcing facility (as such term is defined in section 503B(d)(4) of such Act), either directly or indirectly through a subsidiary.
                                    
                                
                                
                                    (B)
                                    Covered drug
 The term covered drug means—  (i) a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or
                                    
                                    
                                        (ii)
 a drug compounded in accordance with section 503A or 503B of such Act.


================================================================================

Raw Text:
119 S1785 IS: No Handouts for Drug Advertisements Act
U.S. Senate
2025-05-15
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



        II
        119th CONGRESS
        1st Session
        S. 1785
        IN THE SENATE OF THE UNITED STATES
        
            May 15, 2025
            Mr. Hawley (for himself and Mrs. Shaheen) introduced the following bill; which
                was read twice and referred to the Committee
                    on Finance
        
        A BILL
        To amend the Internal Revenue Code of 1986 to deny the deduction for
            advertising and promotional expenses for certain drugs.
    
    
        
            1.
            Short title
 This Act may be cited as the No Handouts for Drug Advertisements Act.
        
        
            2.
            Disallowance of deduction for advertising and promotional expenses for certain
                drugs
            
                (a)
                In general
 Part IX of subchapter B of chapter 1 of subtitle A of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:
                
                    
                        280I.
                        Disallowance of deduction for direct-to-consumer advertising of
                            certain drugs
                        
                            (a)
                            In general
 No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of covered drugs for any taxable year.
                        
                        
                            (b)
                            Direct-to-Consumer advertising
 For purposes of this section—  (1) In general The term direct-to-consumer advertising means any dissemination, by or on behalf of a covered entity, of an advertisement which—
                                
                                    (A)
 is in regard to a covered drug, and   (B) primarily targeted to the general public, including through—
                                    
                                        (i)
 broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and
                                    
                                    
                                        (ii)
 dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications).
                                    
                                
                            
                            
                                (2)
                                Exception
 Such term shall not include an advertisement made through publication in journals and other periodicals.
                            
                            
                                (3)
                                Other terms
 For purposes of this subsection—
                                
                                    (A)
                                    Covered entity
 The term covered entity means—  (i) a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or
                                    
                                    
                                        (ii)
 a person that owns an outsourcing facility (as such term is defined in section 503B(d)(4) of such Act), either directly or indirectly through a subsidiary.
                                    
                                
                                
                                    (B)
                                    Covered drug
 The term covered drug means—  (i) a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or
                                    
                                    
                                        (ii)
 a drug compounded in accordance with section 503A or 503B of such Act.
                                    
                                
                            
                        
                    
                    .
                
            
            
                (b)
                Conforming amendment
 The table of sections for such part IX of the Internal Revenue Code of 1986 is amended by adding after the item relating to section 280H the following new item:
                
                    
                        Sec.
                            280I. Disallowance of deduction for direct-to-consumer advertising of
                            certain drugs.
                    
                    .
                
            
            
                (c)
                Effective date
 The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.